Clinical Case Database / Category: Patient Management
Management of the cystic fibrosis patient in the medical assessment unit
Publication details
Dr Jamie Duckers, Dr Lydia Guhaniyogi
Foundation Years Journal, volume 9, issue 4, p.38 (123Doc Education, London, April 2015)
Abstract
Cystic fibrosis (CF) is an autosomal recessive multi-system disease that can result in different presentations in the acute setting. Managing CF can be challenging and daunting for the foundation doctor. A stepwise approach, with input from the local CF team, can ensure that patients are managed as a whole. We will discuss the management of common presentations.
Access the Clinical Cases Database
A subscription is required to read the full article. Please subscribe using one of the options below.
| Product | Price | Subscription | |
|---|---|---|---|
| Foundation Years Clinical Cases Database | £29.00 | 6 months | |
| Foundation Years Clinical Cases Database | £39.00 | 12 months |
Authors
Dr Jamie Duckers
Consultant Respiratory Physician
All Wales Cystic Fibrosis Centre, University Hospital Llandough
Penlan Road, Vale of Glamorgan, CF64 2XX
jamie.duckers@wales.nhs.uk
Dr Lydia Guhaniyogi (Corresponding author)
Core Medical Trainee Doctor Year 3, University Hospital Llandough
Penlan Road, Vale of Glamorgan, CF64 2XX
lydia.guhaniyogi@wales.nhs.uk
References
1. UK Cystic Fibrosis Trust Antibiotic Working Group. Antibiotic treatment for cystic fibrosis. Report of the UK Cystic Fibrosis Trust Antibiotic Group, 3rd edition. London: Cystic Fibrosis Trust 2009.
2. Plummer A, Wildman M. Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2013 (Issue 5) Art. No.: CD006682. DOI: 10.1002/14651858. CD006682.pub4.
3. Nash EF, Ohri CM, Stephenson AL, Durie PR. Abdominal pain in adults with cystic fibrosis. European journal of gastroenterology & hepatology 2014, 26:129-136.
4. Stecenko AA, Moran A. Update on cystic fibrosis-related diabetes. Current opinion in pulmonary medicine 2010, 16:611-615.
5. UK Cystic Fibrosis Trust Diabetes Working Group. Management of cystic fibrosis related diabetes mellitus. Bromley: Cystic Fibrosis Trust 2004.
6. Saldanha IJ, Akinyede O, Mckoy NA, Robinson KA. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Cochrane Database of Systematic Reviews 2013 (Issue 12) Art. No.: CD009421. DOI: 10.1002/14651858.CD009421.pub2.
7. Penninga L, Penninga EI, Møller CH, Iversen M, Steinbrüchel DA, Gluud C. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database of Systematic Reviews 2013 (Issue 5) Art. No.: CD008817. DOI:10.1002/14651858.CD008817.pub2.
8. Palmer S, Wolfe C, Zaas A. Bacterial infections following lung transplantation: UpToDate Jan 2015 http://www.uptodate.com/contents/bacterial-infections-following-lung-transplantation
9. Fishman J. Infection in the solid organ transplant recipient. UpToDate March 2015 http://www.uptodate.com/contents/infection-in-the-solid-organ-transplant-recipient
Disclaimers
Conflict Of Interest
The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).
Financial Statement
The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.
Patient Consent statement
All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.
Animal & Human Rights
When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.
About the Clinical Cases Database
The Foundation Years Clinical Cases Database is a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.
The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.